Advanced Cancer Detection

Advanced screening panel using liquid biopsy and specialized blood markers to detect early biological signals associated with cancer development, often before symptoms appear.

CHF695.00
35 Biomarkers
0 Health Domains
48h Results
ISO 15189 Certified
Advanced Cancer Detection

What This Measures

Liquid Biopsy (ctDNA, cfDNA, CTCs)

Analyzes microscopic material released by cells into the bloodstream. It evaluates circulating tumor DNA (ctDNA) for abnormal fragments, cell-free DNA (cfDNA) for cellular damage insights, and circulating tumor cells (CTCs) to detect rare cells that may break away from tumors.

Optional Extended Tumor Markers (CA 19-9, Expanded CEA)

Analyzes proteins sometimes associated with cancers. CA 19-9 is linked to pancreatic and gastrointestinal activity, while expanded CEA helps detect abnormal activity tied to colorectal, lung, and other cancer types.

Why It's Important

  • Many cancers develop silently for years before noticeable symptoms appear.
  • Routine traditional check-ups may miss subtle early warning signs.
  • This panel can detect microscopic DNA fragments shed by potentially abnormal cells.
  • It can highlight hidden risks before they become visible symptoms.
  • It can guide proactive imaging or medical follow-up when needed.
  • It provides a deeper baseline for those with heightened risk factors.

Potential Benefits

  • Earlier detection of possible cancer-related signals and abnormal cellular activity.
  • Opportunity for timely, non-invasive blood-based screening.
  • Supports proactive health, longevity, and prevention strategies.
  • Helps guide fast, precise medical follow-up and imaging if needed.
  • Peace of mind through advanced microscopic visibility into cellular health.

Who May Benefit Most

  • Individuals with a strong family history of cancer or genetic predispositions.
  • Those seeking advanced preventive screening beyond standard bloodwork.
  • People focused on longevity and proactive health monitoring.
  • Individuals with lifestyle, occupational, or environmental risk factors.
  • Anyone seeking deeper visibility into long-term health.

Important to Know

  • This is an advanced screening and risk assessment tool, not a definitive or standalone cancer diagnosis.
  • Abnormal findings do not automatically mean cancer is present, as signals can arise from other biological factors.
  • Results must be interpreted clinically and may require follow-up imaging, repeat testing, or specialist consultation.

Conditions Addressed:

Early biological signals linked to cancer development
Abnormal cellular activity
Hidden cancer-related risk signals
CHF695.00